Candida glabrata endophthalmitis treated successfully with caspofungin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15714407.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed.
Medical subject headings
- Candida glabrata
- Candidiasis
- Endophthalmitis
- Peptides, Cyclic